FDA TB drug approval a milestone, with caveats
The U.S. Food and Drug Administration’s approval of the first new drug to treat tuberculosis in nearly half a century and the agency’s first use of its accelerated approval process to speed...
View ArticleCDC report on U.S. TB drug shortage reflects local and global challenges
With no medicine on hand, a father and his infant who have just been diagnosed with multidrug-resistant tuberculosis go untreated, the delay prolonging their recoveries as well as the time they will...
View ArticleIOM report looks at global scope of fake and substandard drugs, while study...
The report released this morning by the Institute Of Medicine portrays a global and growing danger that is both deadly and resource draining, brings the highest risks in the poorest countries, and...
View ArticleEntrepreneur uses cell phones to fight counterfeit drugs while linking...
“In healthcare we have to work with what’s already happening” Nathan Sigworth was a freshman in college when he spent a month visiting a small hospital in India, and made a simple discovery: economics...
View ArticleTB Week: Survivors and allies recount illness, treatment, and loss
In the week leading up to International Tuberculosis Day, which commemorates the discovery by Robert Koch of the cause of the disease in 1882, Science Speaks will look at issues, events and efforts to...
View ArticleTB Week: Integration, involvement, a “holistic” approach key to linking women...
When a week of events focusing on the worldwide impact of tuberculosis brings together a group to talk about women’s health and diplomacy, it needs to be a broad-based group, and it was. For a start,...
View ArticleWHO guidance on first new TB treatment in five decades offers hope,...
WHO cites need to prevent new drug resistance, protect first treatment advance in more than 40 years The World Health Organization’s release this week of interim policy guidelines on the use of...
View ArticleBriefing speakers, report: antibiotic resistant infections “pose a...
When Rep. Gene Green (D-TX) practiced as an attorney in Texas during the 1980s, some of his clients had become infected with tuberculosis that had become resistant to the first and best line of...
View ArticleStudy says healthcare shortcomings leave tuberculosis undiagnosed, untreated
Categories: Drug Resistance, GeneXpert, TBIn a prospective autopsy study published in The Lancet of patients who died at a hospital in Lusaka, Zambia, researchers found a large percentage of patients...
View ArticleSenators call on White House for bold TB Action Plan
Categories: Drug Resistance, TBWith the deadline for submitting a national action plan to combat multidrug-resistant tuberculosis quickly approaching, a group of Senators has sent a letter to the White...
View Article
